Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 14/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 6/20 | 0.43 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7476109 | 0.98 | TLR8 (0.49) | TLR8NPSR1KDM4EL3MBTL1TLR7 | |
| SCHEMBL9125039 | 0.89 | TLR8 (0.53) | TLR8TLR7CRHR1CYP3A4 | |
| SCHEMBL22710280 | 0.87 | PDE10A (0.43) | TLR8NPSR1KDM4EL3MBTL1TLR7 | |
| SCHEMBL12284382 | 0.80 | STK17A (0.38) | TLR8NPSR1KDM4EL3MBTL1KMT2A | |
| SCHEMBL2511088 | 0.80 | KMT2A (0.41) | TLR8NPSR1KDM4ETLR7KMT2A | |
| SCHEMBL8695685 | 0.79 | TLR8 (0.64) | TLR8L3MBTL1TLR7 | |
| SCHEMBL2510236 | 0.79 | KDM4E (0.41) | TLR8KDM4ETLR7KMT2ASMN1; SMN2 | |
| SCHEMBL21268680 | 0.79 | CXCR2 (0.43) | TLR8NPSR1KDM4EL3MBTL1TLR7 | |
| SCHEMBL9125885 | 0.78 | TLR8 (0.49) | TLR8TLR7CYP3A4 | |
| SCHEMBL21268641 | 0.77 | CXCR2 (0.44) | TLR8NPSR1KDM4EL3MBTL1TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6448261-B1 | CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-09-10 | — | — | US | disclosed |
| EP-0935601-A4 | ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES | DU PONT PHARM CO (US) | 2002-08-07 | — | — | EP | disclosed |
| US-6107300-A | CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PSYCHOLOGICAL DISORDERS | DUPONT PHARMACEUTICALS (US) | 2000-08-22 | — | — | US | disclosed |
| EP-0935601-A2 | ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES | Du Pont Pharmaceuticals Company (US) | 1999-08-18 | — | — | EP | disclosed |
| WO-1997035539-A2 | ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES | DU PONT PHARMACEUTICALS COMPANY (US) | 1997-10-02 | — | — | WO | disclosed |